---
title: "\"Waning Profit Warning\" WAI YUEN TONG forecasts that mid-term net profit will decrease to no more than 3 million yuan"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/266221115.md"
description: "WAI YUEN TONG issued a profit warning, expecting a net profit of no more than HKD 3 million for the six months ending in September, compared to HKD 23.7 million in the same period last year. The decrease in profit is mainly due to weak consumer demand in the retail market during the period, resulting in a revenue decline of approximately 7%, with gross profit correspondingly decreasing; the net income from property sales significantly decreased; and the fair value gains from investment properties decreased"
datetime: "2025-11-17T14:04:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266221115.md)
  - [en](https://longbridge.com/en/news/266221115.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266221115.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/266221115.md) | [繁體中文](https://longbridge.com/zh-HK/news/266221115.md)


# "Waning Profit Warning" WAI YUEN TONG forecasts that mid-term net profit will decrease to no more than 3 million yuan

WAI YUEN TONG (00897.HK) issued a profit warning, expecting a net profit of no more than HKD 3 million for the six months ending in September, compared to HKD 23.7 million in the same period last year. The decrease in profit is mainly due to weak consumer demand in the retail market during the period, leading to a revenue decline of approximately 7%, and a corresponding decrease in gross profit; the net income from property sales has significantly decreased; and the fair value gains from investment properties have decreased

### 相关股票

- [WAI YUEN TONG (00897.HK)](https://longbridge.com/zh-CN/quote/00897.HK.md)

## 相关资讯与研究

- [Wai Yuen Tong Issues Profit Warning Amid Market Challenges](https://longbridge.com/zh-CN/news/266185694.md)
- [Wai Yuen Tong Announces Board Meeting to Review Interim Results](https://longbridge.com/zh-CN/news/265310948.md)
- [CICC Sticks to Its Buy Rating for CIMC Enric Holdings (CIMEF)](https://longbridge.com/zh-CN/news/281132485.md)
- [Osl Group FY adjusted non-IFRS income HK$534.1 million](https://longbridge.com/zh-CN/news/281223382.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/zh-CN/news/281325910.md)